Answers are grounded in this paper and cite their sources.
Prospective evaluation shows improved function and palatability in Warmblood horses with chronic lameness, suggesting potential benefits.
Introduction Osteoarthritis is a leading cause of equine lameness, yet pragmatic evidence for nutraceuticals in horses remains limited. Methods We prospectively evaluated 12 weeks of daily natural eggshell membrane (NEM; 12 mg/kg, orally) supplementation in Warmblood horses with chronic lameness using a single-arm before–after design. Ten horses were enrolled and prespecified paired contrasts compared visit 3 (V3, week 12) with baseline (V1). Outcomes included rider-reported under-saddle function (walk and trot), examiner-graded lameness (rest and walk–trot composite), simple joint-angle kinematics (degrees), and owner-rated palatability. Results Rider-reported function improved by approximately half a grade at both walk and trot, and owner-rated palatability improved markedly. Examiner walk-trot scores showed a small trend toward improvement, while rest lameness remained unchanged. Statistical inference supported these patterns, with 95% confidence intervals (CIs) excluding zero for rider scores (Δ = −0.50) and palatability (Δ = −1.50). Moderate changes were observed in right-fore joint angle (Δ = +3.06°) and examiner composite grades (Δ = −0.11). These effects were supported by small-sample inference (permutation tests, bootstrap CIs) and complementary Bayesian estimation. Discussion and conclusion NEM showed potential short-term improvements in owner-reported function and examiner-graded gait, but larger controlled studies are needed.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: